Home  /  Resource Library  /  Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients

Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients

ASH 2019: Study examined the safety and efficacy of acalabrutinib for treatment of CLL in the real world.